Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study

首页> 外文期刊>Journal of Neurology, Neurosurgery and Psychiatry >Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study

【24h】

Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study

机译：Fingolimod对儿科发病患者MRI结果的影响：第3阶段范式研究的结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective

机译：客观的

著录项

来源
《Journal of Neurology, Neurosurgery and Psychiatry》 |2020年第5期|共10页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学;
关键词

相似文献

外文文献
中文文献
专利

1. Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study [J] . Journal of Neurology, Neurosurgery and Psychiatry . 2020,第5期

机译：Fingolimod对儿科发病患者MRI结果的影响：第3阶段范式研究的结果
2. No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) study [J] . Zivadinov Robert, Khan Nasreen, Korn Jonathan R., Current medical research and opinion . 2018,第8期

机译：没有证据临床实践中私人或学术中心接受Fingolimod患者的疾病活动：对美国（MS-MRIUS）研究的多发性硬化，临床和磁共振成像结果的回顾性分析
3. Natalizumab vs fingolimod in patients with active relapsing-remitting multiple sclerosis (RRMS): comparative MRI assessments of disease activity from reveal, a randomized, head-to-head phase 4 study [J] . S. Licata, H. Butzkueven, D. Jeffery, Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology . 2017,第期

机译：Natalizumab与Fingolimod患者有活性复发 - 延长多发性硬化症（RRMS）：来自揭示，随机的头部到头期4研究的疾病活动的比较MRI评估
4. Incremental diagnostic information obtained via novel Dynamic Contrast Enhanced MRI framework applied on Multiple Sclerosis patients: A preliminary study [C] . Eleftherios E. Kontopodis, Georgios C. Manikis, Katerina Nikiforaki, IEEE EMBS International Conference on Biomedical and Health Informatics . 2018

机译：通过适用于多发性硬化症患者的新型动态对比增强MRI框架获得的增量诊断信息：初步研究
5. Neuroprotective Properties of Fingolimod in an Experimental Model of Multiple Sclerosis-Induced Optic Neuritis [D] . Candadai, Amritha Anand. 2020

机译：多发性硬化症诱导视神经炎实验模型中Fingolimod的神经保护性能
6. Original research: Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study [O] . Douglas L Arnold, Brenda Banwell, Amit Bar-Or, -1

机译：原始研究：芬戈莫德对小儿发作性多发性硬化症患者MRI结果的影响：PARADIGMS 3期研究的结果
7. Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study [O] . Douglas L Arnold, Brenda Banwell, Amit Bar-Or, 2020

机译：Fingolimod对儿科发病多发性硬化症患者MRI结果的影响：3阶段3域研究结果

Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study

摘要

著录项

相似文献

相关主题

期刊订阅